Therapie des zystoiden Makulaödems bei Pseudophakie
Tóm tắt
Das funduskopisch sichtbare zystoide Makulaödem nach unkomplizierter Kataraktoperation (PZMÖ) tritt in 1–3% der Fälle auf. Es hat eine gute Prognose. Nur 10% der Ödeme persistieren über 2 Jahre hinaus. Die prophylaktische Behandlung von Augen ohne Begleiterkrankungen mit nichtsteroidalen Antiphlogistika (NSAD) und Steroiden hat keinen Einfluss auf den Endvisus. Unter bestimmten Voraussetzungen scheint sie jedoch sinnvoll. Es werden Risikofaktoren besprochen, die das Entstehen eines PZMÖ begünstigen. Der Verlauf des akuten und chronischen PZMÖ ist zwar medikamentös beeinflussbar – insgesamt ist die Studienlage, was die Behandlung dieses häufigen Problems angeht, jedoch schlecht. In diesem Zusammenhang möchten wir das Freiburger Therapieschema zum PZMÖ vorstellen.
Tài liệu tham khảo
Benhamou N, Massin P, Haouchine B et al. (2003) Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol 135: 246–249
Bolz M, Michels S, Geitzenauer W et al. (2006) Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment. Br J Ophthalmol [Epub ahead of print]
Bradford JD, Wilkinson CP, Bradford RH Jr. (1988) Cystoid macular edema following extracapsular cataract extraction and posterior chamber intraocular lens implantation. Retina 8: 161–164
Cordero CM, Sobrin L, Onal S et al. (2007) Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology [Epub ahead of print]
Cox SN, Hay E, Bird AC (1988) Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 106: 1190–1195
Farber MD, Lam S, Tessler HH et al. (1994) Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study. Br J Ophthalmol 78: 4–7
Flach AJ (1989) Cystoid macular edema following cataract surgery. Arch Ophthalmol 107: 166–167
Flach AJ (1998) The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 96: 557–634
Flach AJ, Dolan BJ, Irvine AR (1987) Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Am J Ophthalmol 103: 479–486
Flach AJ, Graham J, Kruger LP et al. (1988) Quantitative assessment of postsurgical breakdown of the blood-aqueous barrier following administration of 0.5% ketorolac tromethamine solution. A double-masked, paired comparison with vehicle-placebo solution study. Arch Ophthalmol 106: 344–347
Flach AJ, Jampol LM, Weinberg D et al. (1991) Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol 112: 514–519
Flach AJ, Stegman RC, Graham J et al. (1990) Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Ophthalmology 97: 1253–1258
Fung WE (1985) Vitrectomy for chronic aphakic cystoid macular edema. Results of a national, collaborative, prospective, randomized investigation. Ophthalmology 92: 1102–1111
Gass JD, Anderson DR, Davis EB (1985) A clinical, fluorescein angiographic, and electron microscopic correlation of cystoid macular edema. Am J Ophthalmol 100: 82–86
Gass JD, Norton EW (1966) Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol 76: 646–661
Gass JD, Norton EW (1966) Fluorescein studies of patients with macular edema and papilledema following cataract extraction. Trans Am Ophthalmol Soc 64: 232–249
Gehring JR (1968) Macular edema following cataract extraction. Arch Ophthalmol 80: 626–631
Haritoglou C, Kook D, Neubauer A et al. (2006) Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26: 999–1005
Heier JS, Topping TM, Baumann W et al. (2000) Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology 107: 2034–2038
Hitchings RA (1977) Aphakic macular oedema: a two-year follow-up study. Br J Ophthalmol 61: 628–630
Irvine SR (1953) A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol 36: 499–619
Jain R, Stevens JD, Bunce CV et al. (2001) Ischaemic heart disease may predispose to pseudophakic cystoid macular oedema. Eye 15: 34–38
Jaissle GB, Ziemssen F, Petermeier K et al. (2006) Bevacizumab for treatment of macular edema secondary to retinal vein occlusion. Ophthalmologe 103: 471–475
Jonas JB, Kreissig I, Degenring R (2003) Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol 121: 729–730
Jonas JB, Kreissig I, Degenring RF (2003) Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 136: 384–386
Kraff MC, Sanders DR, Jampol LM et al. (1982) Prophylaxis of pseudophakic cystoid macular edema with topical indomethacin. Ophthalmology 89: 885–890
Kube T, Sutter M, Trittler R et al. (2006) Carboxymethylcellulose as a new carrier substance for intravitreal injection of reproducible amounts of triamcinolone. Graefes Arch Clin Exp Ophthalmol 244: 1385–1390
Martin NF, Green WR, Martin LW (1977) Retinal phlebitis in the Irvine-Gass syndrome. Am J Ophthalmol 83: 377–386
Mason JO III, Albert MA Jr, Vail R (2006) Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina 26: 356–357
Melo GB, Farah ME, Aggio FB (2007) Intravitreal injection of bevacizumab for cystoid macular edema in retinitis pigmentosa. Acta Ophthalmol Scand, doi:10.1111/j.1600-0420.2006.00872.x
Miyake K (1985) Vitreous fluorophotometry in aphakic or pseudophakic eyes with persistent cystoid macular edema. Jpn J Ophthalmol 29: 146–152
Miyake K, Ibaraki N (2002) Prostaglandins and cystoid macular edema. Surv Ophthalmol (Suppl 1) 47: S203–S218
Miyake K, Ota I, Ibaraki N et al. (2001) Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch Ophthalmol 119: 387–394
Miyake K, Ota I, Maekubo K et al. (1999) Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Arch Ophthalmol 117: 34–40
Moldow B, Sander B, Larsen M et al. (1998) The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema. Graefes Arch Clin Exp Ophthalmol 236: 881–889
Peterson M, Yoshizumi MO, Hepler R et al. (1992) Topical indomethacin in the treatment of chronic cystoid macular edema. Graefes Arch Clin Exp Ophthalmol 230: 401–405
Reis A, Birnbaum F, Hansen LL et al. (2005) Cyclooxygenase-2 inhibitors: a new therapeutic option in the treatment of macular edema after cataract surgery. J Cataract Refract Surg 31: 1437–1440
Rho DS (2003) Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac. J Cataract Refract Surg 29: 2378–2384
Rossetti A, Doro D (2002) Retained intravitreal lens fragments after phacoemulsification: complications and visual outcome in vitrectomized and nonvitrectomized eyes. J Cataract Refract Surg 28: 310–315
Sebag J, Balazs EA (1984) Pathogenesis of cystoid macular edema: an anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol (Suppl) 28: 493–498
Solomon LD (1995) Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. Flurbiprofen-CME Study Group I. J Cataract Refract Surg 21: 73–81
Squirrell D, Bhola R, Bush J et al. (2002) A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br J Ophthalmol 86: 565–571
Stahl A, Agostini HT, Hansen LL et al. (2007) Bevacizumab in retinal vein occlusion – results of a prospective case follow-up study. Graefes Arch Clin Exp Opthalmol [Epub ahead of print]
Steinert RF, Puliafito CA, Kumar SR et al. (1991) Cystoid macular edema, retinal detachment, and glaucoma after Nd:YAG laser posterior capsulotomy. Am J Ophthalmol 112: 373–380
Stern AL, Taylor DM, Dalburg LA et al. (1981) Pseudophakic cystoid maculopathy: a study of 50 cases. Ophthalmology 88: 942–946
Wenzel M, Pham DT, Reuscher A et al. (2006) Derzeitiger Stand der Katarakt und refraktiven Chirurgie. Ophthalmo-Chirurgie 18: 207–215
Wolter JR (1981) The histopathology of cystoid macular edema. Albrecht Von Graefes Arch Klin Exp Ophthalmol 216: 85–101
Yannuzzi LA, Klein RM, Wallyn RH et al. (1977) Ineffectiveness of indomethacin in the treatment of chronic cystoid macular edema. Am J Ophthalmol 84: 517–519
Ziemssen F, Deuter CM, Stuebiger N et al. (2007) Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin). Graefes Arch Clin Exp Ophthalmol [Epub ahead of print]